Simplex Trading
PTCT icon

Simplex Trading’s PTC Therapeutics PTCT Stock Holding History

Simplex Trading’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,180
Closed -$735K – 10113
2026
Q1 		$694K Buy
10,180
+9,639
+1,782% +$683K ﹤0.01% 2899
2025
Q4 		$41.1K Sell
541
-8,385
-94% -$609K ﹤0.01% 5842
2025
Q3 		$547K Buy
+8,926
New +$465K ﹤0.01% 3707
2023
Q3 		– Sell
-2,403
Closed -$89.4K – 9591
2023
Q2 		$97K Buy
+2,403
New +$118K ﹤0.01% 5123
2022
Q3 		– Sell
-8,427
Closed -$413K – 10684
2022
Q2 		$337K Buy
+8,427
New +$295K ﹤0.01% 3948
2021
Q4 		– Sell
-1,278
Closed -$55K – 11239
2021
Q3 		$55K Sell
1,278
-200
-14% -$8.21K ﹤0.01% 7411
2021
Q2 		$62K Buy
+1,478
New +$63.3K ﹤0.01% 7384
2020
Q2 		– Sell
-8,816
Closed -$433K – 8202
2020
Q1 		$393K Buy
+8,816
New +$444K ﹤0.01% 2852
2018
Q4 		– Sell
-23,895
Closed -$859K – 7642
2018
Q3 		$1.12M Buy
23,895
+19,734
+474% +$817K ﹤0.01% 1771
2018
Q2 		$140K Buy
+4,161
New +$130K ﹤0.01% 3893
2018
Q1 		– Sell
-12,350
Closed -$313K – 6717
2017
Q4 		$205K Sell
12,350
-21,700
-64% -$367K 0.01% 1252
2017
Q3 		$681K Buy
34,050
+6,883
+25% +$135K 0.03% 518
2017
Q2 		$497K Buy
27,167
+17,975
+196% +$242K 0.02% 658
2017
Q1 		$90K Sell
9,192
-12,123
-57% -$147K ﹤0.01% 1840
2016
Q4 		$232K Sell
21,315
-98,895
-82% -$1.04M 0.01% 943
2016
Q3 		$1.68M Buy
+120,210
New +$977K 0.11% 159
2016
Q1 		– Sell
-3,263
Closed -$56.6K – 6106
2015
Q4 		$105K Sell
3,263
-1,849
-36% -$54.4K 0.01% 1310
2015
Q3 		$136K Buy
+5,112
New +$219K 0.01% 1171

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Simplex Trading's PTCT Position: Q2 2026 in Review

Simplex Trading sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 10,180 shares — an estimated $735K sold.

Simplex Trading first reported a position in PTCT in Q3 2015 and held it in 18 quarters. The position peaked at $1.68M in Q3 2016. 383 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Simplex Trading reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 10,180 PTC Therapeutics shares in Q2 2026, an estimated $735K.
  • Simplex Trading first reported a position in PTC Therapeutics in Q3 2015 and held it in 18 quarters.
  • Simplex Trading's PTC Therapeutics position peaked at $1.68M in Q3 2016.
  • 383 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.